Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms

A legfontosabb adatok

Ki végzi
Akhilesh Jain
Hol
Hartford (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
15 fő, tervezett
Kezdés
2025. jún. 1.
Várható befejezés
2032. máj. 1.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Physician Modified Aortic Endograft repair for complex aortic aneurysm
A regiszteradat frissítve
2025. augusztus 24.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a juxtarenal abdominal aortic aneurysm (a bulge in the main belly artery near the kidney arteries). They must be at high risk for open surgery and have few or no other approved device options. The trial tests stent grafts modified by the doctor.

Életkor
18 years or older
Nem
Men and women. Women cannot be pregnant. Women who could become pregnant need a negative pregnancy test before joining.
A betegség stádiuma
Juxtarenal aneurysm with at least one of these: diameter ≥ 5.5 cm (2,2 in) in men (≥ 5.0 cm (2 in) in women) or 2 times the normal artery diameter; growth > 0.5 cm (0,2 in) in 6 months; saccular aneurysm at significant risk of bursting; aneurysm causing symptoms; or burst (ruptured) aneurysm. The artery shape and size must fit the device, for example neck diameter between 20 and 32 mm and neck angle ≤ 60°.

A részvétel fő kizáró okai

  • Infected aneurysm or active infection
  • Unstable angina (worsening chest pain)
  • Connective tissue disease of the aorta, such as Marfan's or Ehler's-Danlos syndrome
  • Life expectancy of less than 1 year
  • Can be treated with an FDA approved EVAR or FEVAR device and can wait for it, or can join a manufacturer-sponsored study

A regiszter feltételei, szó szerint

Mind a 26 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient is ≥ 18 years of age
  • Patients who are male or non-pregnant female (females of child bearing potential must have a negative pregnancy test prior to enrollment into the study)
  • Patient or Legally Authorized Representative has signed an Institutional Review Board (IRB) approved Informed Consent Form
  • Patient has a juxtarenal abdominal aortic aneurysm that meets at least one of the following:; An aneurysm with a maximum diameter of ≥ 5.5 cm for male (≥ 5.0 cm for female) or 2 times the normal diameter just proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements; Aneurysm with a history of growth > 0.5 cm in 6 months; Saccular aneurysm deemed at significant risk for rupture; Symptomatic aneurysm; Ruptured aneurysm
  • Patient has patent iliac or femoral arteries, with or without the use of conduit, that will allow endovascular access with the physician modified endovascular graft
  • Patient has a suitable non-aneurysmal proximal aortic neck of ≥ 2 mm inferior to the most distal renal artery ostium
  • Patient has a suitable non-aneurysmal distal iliac artery length (seal zone) of ≥ 15mm. The resultant repair should preserve patency in at least one hypogastric artery
  • Patient has a suitable non-aneurysmal proximal aortic neck diameter between 20 and 32 mm, averaged across the diameters at the Celiac, SMA, at the lowest patent renal artery and at the midpoint of the renal arteries
  • Patient has suitable non-aneurysmal distal common iliac diameters between 8 and 20 mm
  • Patient has juxtarenal aortic neck angulation ≤ 60°
  • Target branch vessel diameter ≥ 5 mm
  • Patient must be willing to comply with all required follow-up exams

Ki nem vehet részt

  • Patient has a major surgical or interventional procedure, not related to the endovascular repair, planned within +/- 30 days of the AAA repair
  • Patient is currently participating in another investigational device or drug clinical trial
  • Patient has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations
  • Patient has a mycotic aneurysm or has an active systemic or local infection that may increase the risk of endovascular infection
  • Patient has unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina)
  • Patient has history of an aortopathic connective tissue disease (e.g. Marfan's or Ehler's-Danlos syndrome)
  • Patient has a known hypersensitivity or contraindication to anticoagulation or contrast media that is not amenable to pre-treatment
  • Patient has known allergy or intolerance to stainless steel, nitiol, or gold (gold-plated tungsten)
  • Patient has a body habitus that would inhibit X-ray visualization of the aorta
  • Patient has a limited life expectancy of less than 1 year
  • Thrombus or excessive calcification within the neck of the aneurysm
  • Branch vessel stenosis ≥ 80 %
  • Patients treatable on label with FDA approved EVAR or FEVAR device and can wait for device availability
  • Subject is willing and eligible to enroll in a manufacturer-sponsored study at the investigational site, or the subject is willing and eligible to participate in a study with a manufacturer-made device at another institution; -

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Hartford HospitalHartford, Egyesült ÁllamokContact: Akhilesh K Jain, MD, FACS, FSVSRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in high-risk subjects considered to be high risk candidates for open surgical repair, have limited or no other options for on label treatment with an FDA approved device, and having appropriate anatomy.

A vizsgálat csoportja

  • Treatment armA vizsgált kezelés

    Kezelés: Physician Modified Aortic Endograft repair for complex aortic aneurysm

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2025. augusztus 24.